ABEO Abeona Therapeutics Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: ABEO

Price (delayed)

$6.09

Market cap

$348.25M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.17

Enterprise value

$311.89M

?
Relative Growth: Rel. Growth: 44
Relative Strength: Rel. Strength: 55
Relative Valuation: Rel. Valuation: 7
Relative Profitability: Rel. Profitability: 17
Highlights
The revenue has soared by 76% since the previous quarter
The company's gross profit has surged by 66% QoQ
The company's quick ratio rose by 12% QoQ but it fell by 4.1% YoY
Abeona Therapeutics's net income has shrunk by 195% QoQ
ABEO's EPS has dropped by 194% since the previous quarter
Sector: Healthcare
Industry: Biotechnology
Website: http://www.abeonatherapeutics.com
Peers: MRK

Key stats

What are the main financial stats of ABEO

ABEO stock price

How has the Abeona Therapeutics stock price performed over time
Intraday
2.18%
1 week
1.75%
1 month
-6.74%
1 year
-14.35%
YTD
15.56%
QTD
-1.46%

Financial performance

How have Abeona Therapeutics's revenue and profit performed over time
Revenue
$25.52M
Gross profit
$17.12M
Operating income
-$81.82M
Net income
-$62.89M
Gross margin
67.1%
Net margin
-246.4%
Abeona Therapeutics's net income has shrunk by 195% QoQ
Abeona Therapeutics's net margin has shrunk by 154% QoQ and by 102% YoY
ABEO's operating margin has soared by 98% YoY and by 49% QoQ
The revenue has soared by 76% since the previous quarter

Price vs fundamentals

How does ABEO's price correlate with its fundamentals

Growth

What is Abeona Therapeutics's growth rate over time

Valuation

What is Abeona Therapeutics stock price valuation
P/E
N/A
P/B
2.71
P/S
13.61
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
12.22
ABEO's EPS has dropped by 194% since the previous quarter
The price to book (P/B) is 36% higher than the last 4 quarters average of 2.0 but 15% lower than the 5-year quarterly average of 3.2
Abeona Therapeutics's equity has decreased by 22% YoY and by 12% QoQ
ABEO's P/S is 93% below its last 4 quarters average of 198.8 and 88% below its 5-year quarterly average of 113.3
The revenue has soared by 76% since the previous quarter

Efficiency

How efficient is Abeona Therapeutics business performance
The company's return on invested capital has shrunk by 198% QoQ and by 166% YoY
The company's return on assets has shrunk by 176% YoY
ABEO's ROS has dropped by 161% since the previous quarter and by 102% year-on-year
Abeona Therapeutics's return on equity has shrunk by 154% YoY

Dividends

What is ABEO's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ABEO.

Financial health

How did Abeona Therapeutics financials performed over time
ABEO's total liabilities is down by 38% YoY and by 3.9% QoQ
The company's total assets fell by 27% YoY and by 10% QoQ
Abeona Therapeutics's debt is 84% lower than its equity
Abeona Therapeutics's equity has decreased by 22% YoY and by 12% QoQ
Abeona Therapeutics's debt has decreased by 17% YoY and by 14% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.